Juha Kotimaa։ New Insights into How APAC Shapes Complement Activation and Inflammation
Juha Kotimaa, Senior Research Scientist at VTT, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Vessels, Thrombosis and Hemostasis:
“Happy to share a study long in the making with Seppo Meri, Riitta Lassila, Mikel Rezola Artero and Annukka Jouppila.
We show an intriguing mechanistical insights into how the dual antiplatelet-anticoagulant APAC modulates complement activation on injured cells – by enhancing C3 opsonization while limiting proinflammatory ”
Riitta Lassila, Professor of Coagulation Medicine at University of Helsinki, shared this post, adding:
“Now that the final manuscript is available in bloodVTH.
I am grateful for this collaboration and attention to the impact of coagulation on complement and the regulatory capacity of an antiplatelet and anticoagulant APAC.”
Title: Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells
Authors: Juha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, Riitta Lassila, Seppo Meri

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 14, 2026, 10:00Benjamin Tur: Putting Iron Deficiency Anemia on the Global Agenda at the Paris Peace Forum’s Child Summit
-
Nov 14, 2026, 09:48Jack Shuang Hou: FDA Approves Bayer’s Sunharbo – First Factor XIa Inhibitor for Secondary Stroke Prevention
-
Nov 14, 2026, 09:42Samwel Mikaye: What Every Patient Should Know About DVT Symptoms and Treatment
-
Nov 14, 2026, 09:37Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk – Thrombosis and Haemostasis Journal
-
Nov 14, 2026, 09:30Ney Carter Borges: Vulnerable Plaque – Imaging and Clinical Significance
-
Nov 14, 2026, 09:25Carmelo Raffo: How Much Antithrombotic Therapy is Truly Necessary after LAAC?
-
Nov 14, 2026, 09:19Mary Cushman: Excellent to Have Jordan Shavit Visit Us for a Virtual Lab Meeting Today
-
Nov 14, 2026, 09:15Chancellor Donald: Heading to ASH 2026 in New Orleans? Let’s Connect on Faculty Opportunities at Tulane
-
Nov 14, 2026, 09:11Sajja Venkatesh: FDA Approved Asundexian, the First Factor XIa Inhibitor